90 related articles for article (PubMed ID: 24681036)
1. Nonspecific pleuritis: optimal duration of follow-up.
DePew ZS; Verma A; Wigle D; Mullon JJ; Nichols FC; Maldonado F
Ann Thorac Surg; 2014 Jun; 97(6):1867-71. PubMed ID: 24681036
[TBL] [Abstract][Full Text] [Related]
2. Outcome of patients with nonspecific pleuritis at thoracoscopy.
Wrightson JM; Davies HE
Curr Opin Pulm Med; 2011 Jul; 17(4):242-6. PubMed ID: 21519267
[TBL] [Abstract][Full Text] [Related]
3. Outcome of patients diagnosed with fibrinous pleuritis after medical thoracoscopy.
Metintas M; Ak G; Cadirci O; Yildirim H; Dundar E; Metintas S
Respir Med; 2012 Aug; 106(8):1177-83. PubMed ID: 22608353
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies.
Davies HE; Nicholson JE; Rahman NM; Wilkinson EM; Davies RJ; Lee YC
Eur J Cardiothorac Surg; 2010 Oct; 38(4):472-7. PubMed ID: 20219385
[TBL] [Abstract][Full Text] [Related]
5. An update of the long-term outcome of patients with nonspecific pleurisy at medical thoracoscopy.
Yu YX; Yang Y; Wu YB; Wang XJ; Xu LL; Wang Z; Wang F; Tong ZH; Shi HZ
BMC Pulm Med; 2021 Jul; 21(1):226. PubMed ID: 34253218
[TBL] [Abstract][Full Text] [Related]
6. [A clinical study of six surgically treated patients with malignant tumors arising from chronic pleuritis and pyothorax].
Watanabe S; Hitomi S; Nakamura T; Isobe J; Okada K; Chihara K; Aoki M; Tamura K; Wada H; Shimizu Y
Nihon Kyobu Geka Gakkai Zasshi; 1989 Feb; 37(2):281-6. PubMed ID: 2549127
[TBL] [Abstract][Full Text] [Related]
7. Does 'idiopathic pleuritis' exist? Natural history of non-specific pleuritis diagnosed after thoracoscopy.
Venekamp LN; Velkeniers B; Noppen M
Respiration; 2005; 72(1):74-8. PubMed ID: 15753638
[TBL] [Abstract][Full Text] [Related]
8. [Diffuse malignant mesothelioma associated with asbestos pleurisy].
Hirano K; Satoh H; Inoue M; Saitoh T; Yazawa T; Ohtsuka M; Hasegawa S
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34(12):1390-4. PubMed ID: 9022326
[TBL] [Abstract][Full Text] [Related]
9. What is the significance of non-specific pleuritis? A trick question.
Janssen J; Maldonado F; Metintas M
Clin Respir J; 2018 Sep; 12(9):2407-2410. PubMed ID: 30004629
[TBL] [Abstract][Full Text] [Related]
10. Non-specific pleuritis in patients with active malignancy.
Vakil E; Ost D; Vial MR; Stewart J; Sarkiss MG; Morice RC; Casal RF; Eapen GA; Grosu HB
Respirology; 2018 Feb; 23(2):213-219. PubMed ID: 29024191
[TBL] [Abstract][Full Text] [Related]
11. Pleural effusion adenosine deaminase (ADA) level and occult tuberculous pleurisy.
Sakuraba M; Masuda K; Hebisawa A; Sagara Y; Komatsu H
Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):294-6. PubMed ID: 19901882
[TBL] [Abstract][Full Text] [Related]
12. Malignant pleural mesothelioma: surgical management in 285 patients.
Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
[TBL] [Abstract][Full Text] [Related]
13. [Adenosine deaminase 2 in the diagnosis of tuberculous pleuritis].
Inase N; Tominaga S; Yasui M; Tsukada Y; Oukouchi M; Miura H
Kekkaku; 2005 Dec; 80(12):731-4. PubMed ID: 16447785
[TBL] [Abstract][Full Text] [Related]
14. Comparison of needle biopsy with pleural fluid analysis for the evaluation of pleural lesions.
Rauniyar SK; Agarwal A; Bhattacharya SK
Nepal Med Coll J; 2004 Dec; 6(2):112-5. PubMed ID: 16295740
[TBL] [Abstract][Full Text] [Related]
15. Chronic follicular pleuritis: a B cell-rich form of nonspecific pleuritis/fibrosis.
Yousem SA
Hum Pathol; 2019 Aug; 90():14-19. PubMed ID: 31054896
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of tissue polypeptide antigen in pleural effusions with malignant pleural mesothelioma].
Tokuyama T; Yoneda T; Hamada K; Yoshikawa M; Fu A; Tomoda K; Nakaya M; Narita N; Tamura M; Kitamura K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jan; 33(1):39-43. PubMed ID: 7699966
[TBL] [Abstract][Full Text] [Related]
17. Malignant pleural mesothelioma: some aspects of epidemiology, differential diagnosis and prognosis. Histological and immunohistochemical evaluation and follow-up of mesotheliomas diagnosed from 1964 to January 1985.
Walz R; Koch HK
Pathol Res Pract; 1990 Feb; 186(1):124-34. PubMed ID: 1690413
[TBL] [Abstract][Full Text] [Related]
18. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Richards WG; Sugarbaker DJ
Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
Lu C; Perez-Soler R; Piperdi B; Walsh GL; Swisher SG; Smythe WR; Shin HJ; Ro JY; Feng L; Truong M; Yalamanchili A; Lopez-Berestein G; Hong WK; Khokhar AR; Shin DM
J Clin Oncol; 2005 May; 23(15):3495-501. PubMed ID: 15908659
[TBL] [Abstract][Full Text] [Related]
20. Non-specific pleuritis: pathological patterns in benign pleuritis.
Karpathiou G; Hathroubi S; Patoir A; Tiffet O; Casteillo F; Brun C; Forest F; Rahman NM; Peoc'h M; Froudarakis ME
Pathology; 2019 Jun; 51(4):405-411. PubMed ID: 31014824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
